The Carrier Screening Market Growth is Accelerated by Advances in Molecular Testing


 Carrier screening is a type of genetic test that identifies carriers of recessive genetic conditions. It analyzes DNA or a person's genome to determine if they carry one of several genes for an inherited disorder. Such disorders include cystic fibrosis, spinal muscular atrophy, and Tay-Sachs disease. Carrier screening is receiving increased demand as it provides prospective parents with reproductive options and timely access to specialized healthcare if both parents are identified as carriers of the same autosomal recessive disorders. The global Carrier Screening Market is estimated to be valued at US$ 2.34 Bn in 2023 and is expected to exhibit a CAGR of 17.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.


Market key trends:

Advances in molecular testing have accelerated the growth of the carrier screening market. Technologies such as next-generation sequencing (NGS) have enabled simultaneous screening of multiple genetic disorders from a single sample with high accuracy and sensitivity. NGS-based panels can screen for over 100 hereditary conditions in one single test, allowing early detection of carrier status. This has streamlined the carrier screening process while delivering comprehensive results faster. Widespread adoption of innovative molecular diagnostic techniques is thus expected to drive the carrier screening market during the forecast period.

Segment Analysis
The global carrier screening market is dominated by the expanded carrier screening sub-segment. This is because expanded carrier screening screens for hundreds of genetic disorders in a single test, unlike traditional carrier screening which screens for less than a dozen diseases. Expanded carrier screening provide comprehensive information to expecting parents and help them make informed family planning decisions.

Key Takeaways
The global carrier screening market is expected to witness high growth over the forecast period of 2023 to 2030. The market size for carrier screening is projected to reach US$ 2.34 Bn by 2023.

Regional analysis
North America currently dominates the global carrier screening market and is expected to continue its dominance over the forecast period. This is due to presence of major players, rising awareness about carrier screening tests among expectant parents, and growing demand for non-invasive prenatal tests in the region. Asia Pacific is expected to be the fastest growing market due to increasing healthcare expenditure and growing medical tourism industry in the region.

Key players
Key players operating in the carrier screening market are Eurofins Scientific (US), Invitae (US), OPKO Health (US), Fulgent Genetics (US), Quest Diagnostics (US), Sema4 (US), Myriad Genetics (US), Illumina (US), and Thermo Fisher Scientific (US). Eurofins Scientific and Invitae together hold over 35% share of the global carrier screening market.

Get more insights on this topic:

Cell therapy Manufacturing Market

Platelet RIch Plasma Market

______________________

Comments

Post a Comment

Popular posts from this blog

Unveiling Health Secrets: Exploring the Potential of Blood-Based Biomarkers

Image
  The human body is a complex and intricate system, often harboring subtle signs of its inner workings. One of the most promising avenues for unlocking these secrets lies within our bloodstream – a treasure trove of information encoded in the form of blood-based biomarkers. These biomarkers, measurable indicators present in the blood, hold the potential to revolutionize healthcare by providing early detection, accurate diagnosis, and personalized treatment approaches. Blood-based biomarkers encompass a wide range of molecules – from proteins and nucleic acids to metabolites and even circulating cells. Researchers have been diligently working to identify specific biomarkers associated with various diseases and conditions. For instance, elevated levels of certain proteins might point to cardiovascular diseases, while specific genetic material could indicate the presence of cancer. By analyzing these biomarkers, clinicians gain valuable insights into an individual's health status, en...
Read more

Revolutionizing Biology: Advancements in Single Cell Analysis Techniques

Image
  Single cell analysis has emerged as a groundbreaking technology that is revolutionizing the field of biology. Traditionally, biological studies were conducted on populations of cells, averaging out the heterogeneity present within them. However, the advent of single cell analysis has enabled scientists to delve into the complexity of individual cells, uncovering a wealth of previously inaccessible information. Advancements in single cell analysis techniques have paved the way for a deeper understanding of cellular heterogeneity, gene expression, and cellular behavior. One of the most remarkable techniques is single-cell RNA sequencing (scRNA-seq), which allows scientists to measure gene expression in individual cells. This breakthrough has led to the identification of rare cell types, understanding of cellular communication networks, and the discovery of novel biomarkers. Moreover, single cell imaging techniques, such as single cell fluorescence microscopy, have enabled research...
Read more

Medical Robots Market Poised to Grow Owing to Improving Healthcare Infrastructure

Image
 The Medical Robots Market is anticipated to witness robust growth due to rising healthcare spending across the globe. Medical robots are used to perform minimal invasive surgeries with greater accuracy and flexibility. Growing preference for Robot-Assisted Surgery (RAS) over conventional open surgeries due to benefits such as shorter recovery time and minimum operative scars has been augmenting demand for medical robots. Key functions include guiding and positioning surgical accessories like guide tubes in radiology and guiding catheter and wires in cardiology. With rising chronic disease prevalence associated with aging populations, the need for more surgical procedures is surging which requires precise action minimally invasive robotic systems can provide. The Global Medical Robots Market is estimated to be valued at US$ 11.47 Bn in 2024 and is expected to exhibit a CAGR of 16% over the forecast period 2023 to 2030. Key Takeaways: Key players operating in the Medical Robo...
Read more